Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 is a subunit of the ferritin complex, the primary intracellular iron storage protein in humans and other species. It possesses ferroxidase activity, enabling the oxidation of Fe²⁺ (ferrous) to Fe³⁺ (ferric) iron, which is subsequently stored inside the ferritin shell in a non-toxic and bioavailable form. The FTH1 gene is located on chromosome 11, and mutations can cause diseases such as Hemochromatosis type 5 and are implicated in neurodegenerative disorders. FTH1 is essential for cellular and organismal iron homeostasis, protection from iron-driven oxidative stress, regulation of ferroptosis (an iron-dependent cell death pathway), and has roles in immune response and cell proliferation. Clinically, serum ferritin (total, not just heavy chain) is used as a biomarker for iron stores, but levels can be elevated in inflammation and malignancy independent of iron load.
Iron chelators: Reduce ferritin iron load, indirectly affect FTH1 function. Small molecules (investigational): May target ferritin to induce degradation or modulate iron release for anti-cancer or neuroprotective effects
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 (FTH1).